Coronavirus information

Visitor restrictions, information for patients and more.

View coronavirus information

FOI 0325 2019/20 Melanoma Cancer Patients

Freedom of Information Request 0325 2019/20

I have a Freedom of Information request about Cancer treatments with your organisation.

1 – How many melanoma patients undergoing treatment are BRAF+ ?

1a -In the past 3 months, how many melanoma patients were treated with the following:

Bevacizumab

Cobimetinib

Dabrafenib

Dabrafenib AND trametinib

Dacarbazine

Encorafenib AND binimetinib

Ipilimumab

Ipilimumab AND Nivolumab

Nivolumab

Pembrolizumab

Trametinib

Vemurafenib

Vemurafenib AND Cobimetinib

Other active systemic anti-cancer therapy

Palliative care

1b – In the past 3 months how many patients were seen who had stage III resectable melanoma

1c – Of all stage III patients seen, how many received a complete resection ?

1d – Of all stage III patients seen, how many were stage III a ?

2 – In the past 3 months, how many Squamous Cell Non-small cell lung cancer (SqNSCLC) patients were treated with:

Afatinib

Atezolizumab monotherapy

Bevacizumab

Docetaxel monotherapy

Durvalumab

Erlotinib

Gemcitabine

Necitumumab

Nivolumab

Paclitaxel

Pembrolizumab monotherapy

Pembrolizumab chemo in combination

Pemetrexed

Ramucirumab

Vinorelbine and cisplatin / carboplatin

Other active systemic anti-cancer therapy [please state]

Palliative care only

3 – In the past 3 months, how many Non Squamous Cell Non-small cell lung cancer (Non SqNSCLC) patients were treated with:

Afatinib

Alectinib

Atezolizumab mono

Atezolizumab + bevacizumab + carboplatin + paclitaxel

Bevacizumab

Brigatinib

Ceritinib

Crizotinib

Dacomitinib

Docetaxel monotherapy

Erlotinib

Gefitinib

Nintedanib with docetaxel

Nivolumab

Osimertinib

Paclitaxel

Pembrolizumab monotherapy

Pembrolizumab chemo in combination

Pemetrexed with carboplatin

Pemetrexed with cisplatin

Ramucirumab

Other active systemic anti-cancer therapy [please state]

Palliative care only

4 – In the past 3 months, how many Urothelial cancer patients were treated with;

Atezolizumab

Carboplatinum in combination with another agent

Carboplatinum single agent

Cisplatinum in combination with another agent

Cisplatinum single agent

Nivolumab

Pembrolizumab

Any other chemo regimen without cisplatinum or carboplatinum

Other active systemic anti-cancer therapy [please state]

Palliative care only

FOI 0325

Thinking of going to Accident and Emergency but not sure if you need to? Try our handy symptom checker.

Try ask A&E

We're improving the accessibility of our websites. If you can't access any content or if you would like to request information in another format, please view our accessibility statement.